Quarterly report pursuant to Section 13 or 15(d)

Going Concern (Details Narrative)

v3.21.1
Going Concern (Details Narrative) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2020
Jan. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
May 10, 2021
Jan. 07, 2021
Cash and cash equivalents     $ 2,839   $ 2,772    
Accounts receivable, net     7,851   8,028    
Total current assets     14,265   14,122    
Total current liabilities     20,461   18,233    
Net loss     4,207 $ 6,494      
Net cash used in operating activities     5,006 7,122      
Repayment of line of credit     $ 1,800      
Centers for Medicare & Medicaid Services [Member]              
Utilization of advance payment against cash payments         $ 2,100    
Secured Promissory Note [Member] | Ampersand 2018 Limited Partnership [Member]              
Debt instrument, face amount             $ 3,000
Secured Promissory Note [Member] | 1315 Capital [Member] | Series B [Member]              
Debt instrument, face amount             $ 2,000
Silicon Valley Bank [Member]              
Repayment of line of credit $ 3,400            
1315 Capital II, L.P. [Member]              
Sale of common stock   20,000          
Proceeds from sale of stock   $ 19,200          
Subsequent Event [Member]              
Cash on hand           $ 6,400